Alamar Biosciences, Inc. (ALMR)
NASDAQ: ALMR · Real-Time Price · USD
29.81
-1.95 (-6.14%)
Nov 13, 2026, 10:28 AM EST - Market open

Alamar Biosciences Stock Forecast

Stock Price Forecast

According to 5 analysts polled by S&P Global, Alamar Biosciences stock has a consensus rating of "Buy" and an average price target of $37. The average 1-year stock price forecast is 24.12% higher than the current stock price, while the lowest is $34 (+14.06%) and the highest is $45 (+50.96%).

Price Target: $37 (+24.12%)
Analyst Consensus: Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$34$37$35$45
Change+14.06%+24.12%+17.41%+50.96%

Analyst Ratings

The average analyst rating for Alamar Biosciences stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart
RatingJun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Strong Buy333333
Buy111111
Hold111111
Sell000000
Strong Sell000000
Total555555

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Bank of America Securities
Bank of America Securities
Hold
Maintains
n/a
HoldMaintainsn/an/aNov 4, 2026
TD Cowen
TD Cowen
Buy
Reiterates
$34 → $36
BuyReiterates$34 → $36+20.76%Nov 4, 2026
J.P. Morgan
J.P. Morgan
Buy
Reiterates
$32 → $35
BuyReiterates$32 → $35+17.41%Aug 11, 2026
Stifel Nicolaus
Stifel Nicolaus
Buy
Maintains
$28 → $32
BuyMaintains$28 → $32+7.35%Aug 11, 2026
Leerink Partners
Leerink Partners
Buy
Initiates
$35
BuyInitiates$35+17.41%May 12, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
122.30M
from 74.21M
Increased by 64.80%
Revenue Next Year
167.89M
from 122.30M
Increased by 37.27%
EPS This Year
-1.17
EPS Next Year
-0.79
from -1.17
Fiscal YearFY 2024FY 2025FY 2026
Period EndingDec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
25.14M74.21M122.30M
Revenue Growth
-195.17%64.80%
Gross Profit
8.61M41.71M72.48M
Gross Margin
34.23%56.20%59.27%
Operating Income
-49.57M-31.33M-58.86M
Net Income
-47.07M-29.82M-67.47M
EPS
---1.17
Free Cash Flow
---90.00M
No. Analysts
--5
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High122.8M
Avg122.3M
Low122.0M

Revenue Growth

Revenue Growth202620272028
High
65.5%
Avg
64.8%
Low
64.4%

EPS Forecast

EPS202620272028
High-1.03
Avg-1.17
Low-1.30

EPS Growth

EPS Growth20272028
High-
Avg-
Low-